Cello Group (CLL)

 

CLL Share PerformanceMore

52 week high140.00 11/05/17
52 week low95.25 31/01/17
52 week change 24.00 (24.74%)
4 week volume907,846 25/10/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Total Voting Rights

RNS Number: 1078V Cello Group plc 31 October 2017 Cello Group plc Total Voting Rights In conformity with the FCA's Disclosure and Transparency Rules, Cello Group plc ("Cello" or the "Company") confirms the following: As at 31 October 2017 Cello's issued share capital consists of 105,003,988 ordinary shares of 10 pence each ("Ordinary Shares"). The Company hol...

Director/PDMR Shareholding

RNS Number: 7452U Cello Group plc 26 October 2017 26 October 2017 Cello Group plc ("Cello" or the "Company") Director/PDMR Shareholding The Company has been notified that, on 26 October 2017, Alistair Shirley, a person closely associated with Jane Shirley, CEO of Cello Health Europe and Cello Health Insight, purchased 2,000 ordinary shares of 10 pence each...

The companies behind AIM's incredible rally

Nimble AIM has thrashed large-cap markets in 2017 by at least 80%. Former AIM writer of the year Andrew Hore reveals...

Grant of Options

RNS Number: 3018S Cello Group plc 29 September 2017 29 September 2017 Cello Group plc ("Cello" or "the Company") Grant of Options The Company notifies that, on 29 September 2017, it granted a total of 1,215,000 options over ordinary shares of 10 pence each ("Options") in the capital of the Company to directors and employees, pursuant to the Company's PSP Opt...

Director/PDMR Shareholding

RNS Number: 0162S Cello Group plc 27 September 2017 27 September 2017 Cello Group plc ("Cello" or the "Company") Director/PDMR Shareholding The Company has been notified that on 27 September 2017 Mark Bentley, Group Finance Director, sold and then re-purchased 110,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares"), in order to ...

Director Deals - Cello Group PLC (CLL)

Mark Scott, Chief Executive Officer, sold post-exercise 194,700 shares in the company on the 22nd September 2017 at a pric...

Director Deals - Cello Group PLC (CLL)

Mark Scott, Chief Executive Officer, exercised 330,000 shares in the company on the 22nd September 2017 at a price of 10.0...

Director Deals - Cello Group PLC (CLL)

Stephen Highley, Executive Director, sold post-exercise 88,500 shares in the company on the 22nd September 2017 at a price...

Fundamental DataMore

EPS-3.23
Dividend yield2.81 %

Latest discussion posts More

  • info

    http://www.proactiveinvestors.co.uk/companies/news/184309/cello-group-confident-of-meeting-full-year-expectations-after-solid-first-half-184309.html?utm_source=Sign-Up.to&utm_m ...
    21-Sep-2017
    forwardloop
  • Re: Question

    Hi Patehan, I can only assume that it's interest leading up to the Interims due on 20th September. I know of nothing else.
    16-Sep-2017
    Lupo di mare
  • Question

    What's going on here the last few days?
    14-Sep-2017
    patehan

Users' HoldingsMore

Users who hold Cello Group also hold..
LLOYDS GRP.44%
ROYAL BANK SCOT30%
TESCO26%
RDS 'B'24%
GLAXOSMITHKLINE22%

Codes & Symbols

ISINGB00B0310763
SymbolsCLL, LSE:CLL, CLL.L, CLL:LN, LON:CLL, XLON:CLL

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account